MeSH Browser

MeSH Supplementary: New York protocol
Unique ID: C048729
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C048729
Entry Term(s): CCG-192P
Registry Numbers: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Methotrexate; Prednisone; Thioguanine; Vincristine
Frequency: 11
Note: chemotherapy protocol consisting of above cpds
Source: J Clin Oncol 1986;4(5):744
Date of Entry: 1986/06/04
Revision Date: 2000/11/30

New York protocol MeSH Supplementary Concept Data 2025